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ABSTRACT
Aminoglycosides antibiotics negate dissociation
and recycling of the bacterial ribosome’s subunits
by binding to Helix 69 (H69) of 23S rRNA. The differ-
ential binding of various aminoglycosides to the
chemically synthesized terminal domains of the
Escherichia coli and human H69 has been
characterized using spectroscopy, calorimetry and
NMR. The unmodified E. coli H69 hairpin exhibited a
significantly higher affinity for neomycin B and
tobramycin than for paromomycin (Kds=0.3±0.1,
0.2±0.2 and 5.4±1.1mM, respectively). The binding
of streptomycin was too weak to assess. In contrast
to the E. coli H69, the human 28S rRNA H69 had a
considerable decrease in affinity for the antibiotics,
an important validation of the bacterial target. The
three conserved pseudouridine modifications
(W1911, W1915, W1917) occurring in the loop of the
E. coli H69 affected the dissociation constant, but
not the stoichiometry for the binding of
paromomycin (Kd=2.6±0.1mM). G1906 and G1921,
observed by NMR spectrometry, figured
predominantly in the aminoglycoside binding to
H69. The higher affinity of the E. coli H69 for
neomycin B and tobramycin, as compared to
paromomycin and streptomycin, indicates differ-
ences in the efficacy of the aminoglycosides.
INTRODUCTION
The 2-deoxystreptamine (2-DOS) aminoglycosides
(Figure 1) are a group of broad spectrum antibiotics
known to interact with the prokaryotic ribosome’s 16S
rRNA in the small (30S) subunit, speciﬁcally with the
helix 44 (h44) decoding or A-site (1,2). Though
aminoglycoside binding of the A-site has become a model
of the antibiotic’s class action (3), aminoglycosides also
bind to the large (50S) subunit of the ribosome (4,5),
and to other RNAs to varying degrees. Other RNAs
studied for their binding of aminoglycosides include
the trans-activating region (TAR) and the Rev pro-
tein response element (RRE) RNA of the human
immunodeﬁciency virus, ribozymes, aptamers and the
human tau protein RNA regulatory element (6–8).
Binding properties of the aminoglycoside are dependent
on the nature of the particular aminoglycoside and the
target RNA. However, as a class the aminoglycosides
appear to bind to unequal, internal loops, to hairpin
loops and to A-minor motifs. The neomycin-class of
aminoglycosides are related by their ringed structures,
neamine, present in all 4,5 2-DOS linked families
(Figure 1C and D). Rings I and II bind to the A-site of
the bacterial ribosome’s small subunit and cause tRNA to
misread mRNA codons (9). Individual H2O molecules
aﬀect the manner in which the diﬀerent aminoglycosides
bind at the A-site by altering the conformation of the
binding site and changing the structure of the
aminoglycosides (10–12). Though their chemical struc-
tures diﬀer, the aﬃnities of the aminoglycosides for the
bacterial ribosome’s A-site are similar. The binding
aﬃnities of the aminoglycosides are related to the
number of hydrogen bonds between the aminoglycosides
and the RNA, whether bound directly or water mediated
(12,13). Paromomycin (Figure 1E) binds in a deep groove
of the 16S rRNA facilitated by direct and water-mediated
hydrogen bonds and causes the nucleosides A1492 and
A1493 to bulge out of conformation (10–12).
Paromomycin also binds in the shallow groove with
another H2O molecule. The shallow groove H2Oi s
observed in the binding of tobramycin (Figure 1D), but
not with geneticin (G-418) (14). Ring III of both
tobramycin and geneticin displaces the H2O molecule
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deep groove (12,14,15).
Aminoglycosides bind to the ribosome’s large subunit,
as well as to the small subunit (15–17). The normal disso-
ciation and recycling of the ribosomal subunits are
aﬀected by the binding of these antibiotics to Helix 69
(H69) of the large subunit (15). H69 interacts with h44
of the small subunit at the interface of the two subunits
(18–20). The contacts between H69 and h44 are similar to
an A-minor interaction (21). This interaction may aﬀect
the eﬃciency and accuracy of speciﬁc steps in translation
(22–25). Ribosome recycling factor (RRF) in conjunction
with elongation factor G normally dissolves the H69-h44
interaction and thus, dissociates the subunits.
However, the binding of the aminoglycosides to H69
restores the structural contacts between the large
and small subunits negating the recycling of the
ribosome (15).
A structural study has detailed the binding of the
aminoglycosides neomycin B (Figure 1C) and gentamicin
to the 50S subunit. The aminoglycosides bind the 23S
rRNA within the major groove of H69 on the 30-side of
the stem at its junction with the terminal loop and include
binding to G1921, U1923 and G1906 (Figure 1A) (15).
Aminoglycoside rings I and II may play a role in the
binding of the antibiotics to H69, as they do in its
Figure 1. Structures of the terminal stems and loops of the E. coli and human helix 69, and of the aminoglycosides. (A) Terminal hairpin sequence
and secondary structure of helix 69 (H69) from the E. coli ribosome. The RNA was synthesized with and without the pseudouridine (W) modiﬁ-
cations at the 23S rRNA positions of 1911, 1915 and 1917. (B) Terminal hairpin sequence and secondary structure of helix 69 from the human
ribosome. The RNA was synthesized without the pseudouridine (W) modiﬁcations which occur naturally at the 28S rRNA positions of 3727, 3731
3733, 3737 and 3739. The chemical structures of the aminoglycosides used in the reported experiments: (C) Neomycin B; (D) Tobramycin; (E)
Paromomycin; (F) Streptomycin.
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decoding site is also found in the terminal hairpin of
H69 (Figure 1A and B), but is not directly involved in
the binding of aminoglycosides to the 23S rRNA. This
hairpin is highly conserved, and post-transcriptionally
modiﬁed with pseudouridines (W). The human H69
hairpin is also modiﬁed with the three Ws, but a G3734
replaces A1918 that is located in the loop of Escherichia
coli H69 (Figure 1A and B).
We postulated that aminoglycoside antibiotics would
bind to a model RNA structure of the unmodiﬁed H69
stem and loop, and that speciﬁc aminoglycosides would
have diﬀerential aﬃnities for the RNA. In addition, we
postulated that the extensive natural W modiﬁcations were
perhaps important, but not necessary to the binding
aﬃnities of the aminoglycosides. The human H69
sequence has a G3734 at the position analogous to
A1918 of the E. coli H69 (Figure 1). This diﬀerence
between the human and bacterial H69 is comparable to
the diﬀerence between the human and bacterial h44
decoding sites in which a G substitutes for A1408 (26).
Because the human h44 has signiﬁcantly reduced aﬃnity
for aminoglycosides in comparison to the E. coli h44 (27),
we believed that whatever aminoglycoside binding
occurred with the E. coli H69, its aﬃnity would be
reduced with the human RNA sequence. Here we report
that the unmodiﬁed E. coli H69 stem- and loop-domain
binds neomycin B, tobramycin and paromomycin, but not
streptomycin, with high aﬃnity and that H69 G1906 and
G1921 are involved in the binding of the aminoglycosides.
The presence of the three almost universally conserved W
modiﬁcations in the loop of the bacterial H69 hairpin
results in a higher aﬃnity of paromomycin. However, a
considerable decrease in aminoglycoside aﬃnity
was observed for the unmodiﬁed human H69 sequence
in comparison to the modiﬁed and unmodiﬁed E. coli
sequences.
MATERIALS AND METHODS
RNA synthesis and puriﬁcation
RNAs corresponding to nucleosides 1906–1924 of the
stem and terminal loop of E. coli 23S rRNA Helix 69
(H69) were chemically synthesized (Dharmacon RNA
Technologies, CO) with and without the three
pseudouridine modiﬁcations (W) that occur at positions
1911, 1915 and 1917 (Figure 1A). In addition, the RNA
corresponding to nucleosides 3722–3740 of the stem and
terminal loop of the human 28S rRNA H69 was chemi-
cally synthesized without the modiﬁcations. The RNAs
were deprotected as suggested by the manufacturer,
lyophilized and dissolved in H2O. The RNAs were
puriﬁed by ion exchange HPLC (28), and concentrations
determined by UV absorbance at 260nm at room temper-
ature (29). The base-paired secondary-structure of the
unmodiﬁed E. coli H69 hairpin was found by nuclear
magnetic resonance (NMR) to be similar to that
previously reported (21,30,31).
Aminoglycoside binding determined by UV-monitored
thermal denaturations
The H69 samples were dissolved to obtain a concentration
of 1mM in cacodylate buﬀer (sodium cacodylate, 10mM;
NaCl, 51.5mM; EDTA, 0.1mM; pH 6.0). H69 RNA
samples were titrated with an aminoglycoside in concen-
trations from 0 to 10mM. Thermal denaturations and
renaturations were monitored by measuring UV
absorbance (260nm) using a Varian Cary 3
spectrophotometer as published (23,24,32,33). The data
points were averaged over 20s and collected three times
a minute with a temperature change of 1 C per minute
from 5 to 95 C. Thermal denaturations and renaturations
were repeated three times at each concentration of
aminoglycoside and conducted on three or four diﬀerent
days providing nine or 12 sets of data from which a
point-by-point average of the thermodynamic proﬁle was
obtained. The ‘melting’ temperature (Tm) varied by no
more than ±0.5 C. The UV data were analyzed as
described (32,34,35) and the thermodynamic parameters
were determined by using Meltwin (35). The binding of
each aminoglycoside to each H69 domain was determined
by plotting the change in Tm with increasing concentration
of the aminoglycoside. Line ﬁtting analyses using a
non-linear regression with a two-site binding were con-
ducted with Prism (GraphPad) from which the dissocia-
tion constants (Kd) were extracted. The Gibb’s free energy
of binding (G ) was determined for a temperature of
37 C and from the relationship of the equilibrium
binding constant to the free energy, G 
37= RTlnKeq.
Circular dichroism spectrapolarimetry and
aminoglycoside binding
Circular dichroism (CD) spectra were recorded at 4 C
using a Jasco J600 spectrapolarimeter and an interfaced
computer (36,37). A jacketed, cylindrical sample cell with
a 1cm light path, was used. RNA sample concentrations
were adjusted with cacodylate buﬀer to  0.2 absorbance
units at 260nm. H69 RNA samples were titrated with an
aminoglycoside to ﬁnal concentrations of 0, 0.75, 1.50,
2.25, 3.00, 4.50, 5.25, 6.00, 6.75, 7.50, 8.25 and 9.00mM.
CD data are baseline corrected for signals due to the cell,
buﬀer and aminoglycoside. Changes in ellipticity at
262nm with increases in aminoglycoside were used to
generate binding curves from which the dissociation con-
stants were extracted using a non-linear regression
analysis with a two-site binding (Prism, GraphPad).
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) (38) was conducted
at 37 C to determine the binding constants and
thermodynamic parameters for aminoglycoside interac-
tion with the unmodiﬁed E. coli and human H69 RNA
hairpins. The H69 samples (40mM in cacodylate buﬀer)
were titrated with 10ml aliquots of an aminoglycoside
solution (250mM in cacodylate buﬀer). Experimental
data was corrected for contributions of buﬀer by subtrac-
tion of a titration of the RNA with buﬀer alone. The
change in heat capacity with increasing concentration of
3096 Nucleic Acids Research, 2010,Vol.38, No. 9aminoglycoside was analyzed using a non-linear regres-
sion with a two-site binding (Prism, GraphPad).
NMR spectrometry
The
1H 1D and 2D NMR spectra were acquired on a
Bruker DRX500 spectrometer (NCSU NMR Facility)
and processed with either XWINNMR (BrukerBiospin
Inc., Rheinstetten, Germany) or NMRPipe (39) and
the analyses were achieved with SPARKY (40) or
ACD-NMR (41). Since the NMR samples were dissolved
in
1H2O, the WATERGATE (42) method was used to
suppress the water signal.
1H 1D NOE diﬀerence (43)
and 2D NOESY (44,45) experiments of the samples in
1H2O were conducted with mixing times of 50 and
250ms, respectively, and performed at low temperature
(2 C) to observe the exchangeable proton resonances.
The titration of E. coli unmodiﬁed H69 with neomycin
B was followed by recording 1D
1H spectra. NMR
samples of the RNA were 0.3–0.6mM in 300mL in 90%
1H2O, 10%
2H2O, 20mM phosphate buﬀer (pH=6.2),
50mM Na
+ and 50mMK
+. Neomycin B (was in
1H2O
solution containing 20mM phosphate buﬀer (pH=6.2),
50mM Na
+ and 50mMK
+. Titrations were performed
by direct addition of small aliquots of neomycin (by
using micro pipettes) to the NMR tube containing
the RNA. All NMR titration experiments were carried
out at 2 C.
RESULTS
Characterization of the terminal hairpin constructs of H69
The terminal hairpin of the E. coli 23S rRNA H69
(nucleosides 1906–1924) was chemically synthesized with
and without the three conserved W modiﬁcations at posi-
tions 1911, 1915 and 1917. The corresponding unmodiﬁed
human sequence of H69 was chemically synthesized from
nucleosides 3722 to 3740 (Figure 1A and B). All three
RNAs were puriﬁed to homogeneity using HPLC. The
three hairpins behaved as unimolecular species when
thermally denaturated and renaturated under conditions
of moderate ionic strength and pH (cacodylate buﬀer, pH
6.0). The RNAs exhibited a major helix to random coil
transition between the temperatures of 50 and 70 C in the
absence of aminoglycosides (Figure 2 and Table 1). The
human H69, which has two A
.U base pairs in the stem, as
opposed to the one for E. coli H69, exhibited the lowest of
the Tm, 52.9 C (Table 1). The three conserved Ws
increased the stability of the E. coli H69 hairpin
(Tm=1.5 C), and that of the human H69 hairpin
(30,31). The unmodiﬁed E. coli H69 hairpin exhibited a
minor thermal transition, as had been reported by others
for the W1911-modiﬁed, E. coli H69 and the unmodiﬁed
human H69 (30,31). The minor transition occurred at a
temperature below 30 C, under the solution conditions we
had used, but was not observed with the modiﬁed E. coli
H69 domain with all three Ws (Figure 2). Thus, the
low-temperature transition could be attributed to the
thermal denaturation of the unmodiﬁed loop nucleosides
that, when modestly stabilized by the modiﬁcations,
cooperatively melts with the major transition.
Pseudouridines on the 30-side of stems and adjacent to
loops, in particular position 39 in the anticodon stem of
tRNAs, are known to stabilize the hairpins (33,46), as is
position 1911 of H69 (47). W contributes little to thermal
stability of tRNA’s canonical TWC loop (48). As observed
here (Table 1) and by others (30,31), W does not appear to
contribute to the thermal stability of the H69 loop, but
does stack with adjacent nucleoside in the H69 loop (47).
Aminoglycoside binding by E. coli H69 and human H69
assessed by UV analyses
The ability of the unmodiﬁed and W-modiﬁed E. coli H69
hairpins, and the unmodiﬁed human H69 sequence to bind
the aminoglycoside antibiotics, neomycin B, tobramycin,
paromomycin and streptomycin (Figure 1 and
Supplementary Figures S1 and S2), was assessed by mon-
itoring changes in the major, UV-monitored, thermal
transitions, CD ellipticity and ITC of the RNAs when
titrated with the aminoglycosides. The binding of
aminoglycosides to a model RNA duplex of the
decoding site of h44 increased the thermal stability of
that RNA (49). With one exception, the binding of
aminoglycosides by the modiﬁed and unmodiﬁed E. coli
Helix 69, as well as the human H69, exhibited an increase
in the Tm of the major thermal transition, as demonstrated
by the unmodiﬁed E. coli H69 bound by neomycin
Figure 2. Thermal denaturations of the unmodiﬁed and modiﬁed
E. coli H69 and the human H69. The unmodiﬁed (blue) and modiﬁed
(red) E. coli H69 and the human H69 (green) RNA hairpins were
subjected to repeated thermal denaturations and renaturations in the
absence of aminoglycosides. The graphs are the results of
point-by-point averages of nine transitions. The thermodynamic param-
eters obtained from the curves are found in Table 1.
Table 1. Thermodynamic parameters of the unmodiﬁed and
W-modiﬁed E. coli H69 hairpins and the unmodiﬁed human H69
hairpin
Helix 69T Thermodynamic parameter
Tm
( C)
a
G 
(kcal/mol)
H
(kcal/mol)
S
(cal/Kmol)
Modiﬁed E. coli 64.7  4.5±0.2  54.8±5.0  126.2±9.6
Unmodiﬁed E. coli 63.2  4.4±0.2  56.7±3.9  168.6±15.1
Unmodiﬁed human 52.9  2.2±0.1  45.9±3.6  140.7±11.2
aTm values from 9 or 12 determinations varied by ±0.5 C.
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H69 RNAs exhibited increases in Tm, or changes in the
melting proﬁle (Figure 3B). We concluded that streptomy-
cin did not bind to the H69 RNAs models that we con-
structed. In contrast when titrated with neomycin B,
tobramycin or paromomycin, the UV-monitored
denaturations of the unmodiﬁed E. coli H69 hairpin
were signiﬁcantly altered (Figure 3B). The three antibi-
otics diﬀerentially aﬀected the Tm, suggesting that each
antibiotic varied in its ability to restructure the unmodiﬁed
E. coli H69 hairpin. Increases in Tm were most readily
eﬀected by tobramycin and neomycin B, and less so by
paromomycin, indicating a diﬀerence in their binding
aﬃnities for the RNA. Analysis of the melting data
(Figure 3B) using non-linear regression produced
binding curves in which the dissociation constant (Kd)
for each antibiotic could be calculated. The resulting
data illustrated that tobramycin was bound to the
unmodiﬁed hairpin loop of E. coli H69 with a Kd of
0.2±0.2mM. Neomycin B and paromomycin also were
bound strongly with Kd values of 0.3±0.1 and
5.4±1.1mM, respectively (Table 2).
The introduction of the W modiﬁcation at the loop posi-
tions 1911, 1915 and 1917 of the E. coli H69 hairpin
resulted in an increased aﬃnity of the RNA for the anti-
biotic. Paromomycin was bound by both the unmodiﬁed
E. coli H69 hairpin and its W-modiﬁed counterpart.
However, the binding curves (Figure 3C) and the Kds
(Table 2) indicated that the presence of modiﬁcations
increased the association of paromomycin by a factor of
two. The modiﬁed H69 bound paromomycin with a Kd of
2.6±0.1mM, whereas that of the unmodiﬁed RNA was
5.4±1.1mM. The three antibiotics also exhibited diﬀer-
ences in their binding aﬃnities for the unmodiﬁed human
H69 hairpin. Again tobramycin was bound with the
highest aﬃnity followed by neomycin B, and ﬁnally
paromomycin with considerably less aﬃnity (Table 2).
Importantly, the three antibiotics were bound by the
human H69 hairpin with aﬃnities that were far less than
that of the E. coli H69. The aﬃnity of the unmodiﬁed
E. coli H69 domain for the antibiotics was as much as
5-fold higher than that of the unmodiﬁed human H69.
Thus, neomycin B, tobramycin and paromomycin
diﬀerentially bound the E. coli H69 hairpin, and did
so with consistently higher aﬃnities than with the
human H69.
The data collected from the aminoglycosides binding to
the E. coli and human H69 constructs corresponded best
to non-linear, two-site interactions (Figure 3B). The
binding of aminoglycosides to other model RNA
systems also have been found to exhibit a better ﬁt with
a two-site analysis (50). Each of the aminoglycosides
exhibited a signiﬁcantly higher aﬃnity for the primary
binding site than the secondary site (Table 2). Neomycin
B and tobramycin exhibited larger diﬀerence in aﬃnity
between the two sites than did paromomycin for which
the Kds doubled. In fact, the second site binding of
tobramycin was too weak to be analyzed. The Gibb’s
free energy of binding (G ) was calculated from the
binding constant for the primary- and secondary-site
interactions of each of the aminoglycosides with the H69
Figure 3. (A) Eﬀect of neomycin B on the thermal stability of the
unmodiﬁed E. coli H69. The unmodiﬁed E. coli H69 (1mM) was
titrated with increasing amounts of neomycin B (0–10mM) and the
complex RNA–neomycin B subjected to repeated thermal
denaturations and renaturations. Each curve is the result of
point-by-point averages of either nine or 12 transitions for each con-
centration: 0mM (blue square), 0.75mM (purple square), 1.50mM (aqua
square), 2.25mM (yellow triangle), 3.00mM (pink square), 4.50mM
(dark red circle), 5.25mM (dark red square), 6.75mM (small blue
square) and 9.00mM (dark cyan square). With increasing amounts of
aminoglycoside, the Tm of the RNA increases. (B) Binding of neomycin
B, tobramycin, paromomycin and streptomycin to the unmodiﬁed
E. coli H69 and to the human H69. The diﬀerences in melting temper-
ature (Tm) of the H69 with the addition of increasing concentrations
of aminoglycoside provided binding curves for each of the
aminoglycosides. Tobramycin bound to the unmodiﬁed E. coli H69
(ﬁlled triangle) and to the human H69 (cross mark); neomycin bound
to the unmodiﬁed E. coli H69 (ﬁlled circle) and to the human H69
(ﬁlled rhombus); paromomycin bound to the unmodiﬁed E. coli H69
(ﬁlled square) and to the unmodiﬁed human H69 (inverted ﬁlled
triangle). Streptomycin was not bound by the unmodiﬁed E. coli H69
and thus, was assessed at two concentrations only (open square). The
binding of paromomycin to the W-modiﬁed E. coli H69 is also shown
(double dagger). Addition of streptomycin did not increase the Tm. The
binding aﬃnities (Kd) and free energy of binding (G ) for each
aminoglycoside and for the diﬀerent H69 are shown in Table 2.
(C) The binding of paromomycin to the unmodiﬁed and W-modiﬁed
E. coli H69 and human H69. The unmodiﬁed (red square) and
W-modiﬁed (blue triangle) E. coli and human H69 (light-blue inverted
triangle) (1mM) were titrated with paromomycin (0–10mM) and the
RNA was thermally denatured and renatured, repeatedly. Binding
curves were extracted from the diﬀerences in melting temperature
(Tm) of the two H69 RNAs with the addition of increasing concen-
trations of aminoglycoside. The binding aﬃnities (Kd) and free energy
of binding (G ) paromomycin by the unmodiﬁed and W-modiﬁed
E. coli H69 are shown in Table 2.
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of paromomycin to the modiﬁed and unmodiﬁed E. coli
H69 was found to be inconsequential (Table 2). However,
the diﬀerences in free energy between neomycin B and
tobramycin binding to the unmodiﬁed E. coli H69
and that of the paromomycin were considerable
(G   2kcal/mol) (Table 2). Diﬀerences in free energy
for each aminoglycoside binding to the unmodiﬁed E. coli
when compared to the same antibiotic binding to the
human H69 hairpin were less (G   1kcal/mol). A
Hill analysis was applied to what appeared as a two-site
binding of paromomycin to all three RNAs
(Supplementary Figure S3). The two-site line ﬁtting
analysis of the melting proﬁles, and the Hill coeﬃcients
(n) derived from the Hill plot being >1, suggested a
modest positive cooperativity in the binding of the
paromomycin to the RNA. The coeﬃcient for the
unmodiﬁed H69 was equivalent to that of the modiﬁed
H69 (n=1.53 and 1.48), within error (±0.05). However,
the human H69 hairpin had a signiﬁcantly lower coeﬃ-
cient, 1.33.
Aminoglycoside binding observed by CD
CD spectropolarimetry of RNA detects changes in base
stacking throughout the RNA, stems and loops with
changes in solution conditions, modiﬁcation and the
binding of ligands (51,52). CD has the advantage that
many interacting small compounds, including ions, and
even peptides and proteins exhibit spectral nulls at the
wavelengths that RNA demonstrates the largest ellipticity
250–290nm (52–54). Though we had not tested the aﬀect
of changing ionic conditions on aminoglycoside binding to
H69, the structure of a human H69 construct was little
aﬀected by the addition of MgCl2 (31). The CD experi-
ments were performed to conﬁrm the data collected from
the UV-monitored thermal transitions of the unmodiﬁed
E. coli and human H69 constructs titrated with the
aminoglycosides. CD ellipticity changed with increasing
concentrations of aminoglycoside (Figure 4). Titration of
the unmodiﬁed E. coli H69 with paromomycin increased
the ellipticity at low concentrations approximating the Kd
of the primary binding site. An increased ellipticity is
associated with an increase in stacking and therefore,
would be consistent with an increase in the Tm as the
RNA is titrated with the aminoglycoside. The aﬃnity of
the unmodiﬁed E. coli H69 for paromomycin as deter-
mined from the CD data diﬀered little from that
determined from the thermal denaturation experiments
(Kd=3.5 versus 5.4mM, respectively). With increasing
concentrations of the aminoglycoside, the ellipticity of
the CD spectra decreased (Figure 4) and the second site
binding constant again approximated that derived from
the thermal denaturations, but was higher (Kd=9.6
versus 6.4mM, respectively). The human H69 exhibited a
weaker aﬃnity for paromomycin than did the E. coli H69.
The primary binding site had a dissociation constant more
than 10-fold higher than that of the unmodiﬁed E. coli
H69 (Kd=39.6 versus 3.5mM, respectively). The Kd
derived from the CD analysis was consistent with that
obtained from the thermal denaturations (Kd=39.6
versus 35.6mM, respectively).
H69 binding of neomycin observed with ITC
ITC determines the change in heat capacity of a
macromolecule with the binding of a ligand (38). Thus,
the data is a direct measure of energy changes in the
system, even for single-stranded RNA (55). In comparison
to ITC, changes in an RNA’s thermal denaturation with
addition of increasing amounts of ligand as determined by
UV absorbance are an indirect measure of the energy
changes. Though ITC consumes considerable amounts
of H69 hairpin, it is complementary to, and conﬁrms
other measurements of thermal stability when small
ligands are bound by RNAs (56). Therefore, in order to
determine if the UV-monitored thermal denaturations
Table 2. Binding of aminoglycoside antibiotics to E. coli and human helix 69
Helix 69 construct and aminoglycoside Kd (mM) G37
  (kcal/mol)
Site 1 Site 2 Site 1 Site 2
Modiﬁed E. coli Helix 69+Paromomycin 2.6±0.1 4.9±0.3  7.9  7.5
Unmodiﬁed E. coli Helix 69+Paromomycin 5.4±1.1 6.4±0.9  7.5  7.4
Unmodiﬁed E. coli Helix 69+Neomycin B 0.3±0.1 4.3±0.7  9.3  7.6
Unmodiﬁed E. coli Helix 69+Tobramycin 0.2±0.2 4.5±0.3  9.5  7.6
Unmodiﬁed Human 69+Paromomycin 18.4±1.7 35.6±1.1  6.7  6.3
Unmodiﬁed Human 69+Neomycin B 1.5±0.3 3.7±0.1  8.2  7.7
Unmodiﬁed Human 69+Tobramycin 0.5±0.1 N/A  9.0 N/A
Figure 4. Paromomycin binding to the unmodiﬁed E. coli H69 detected
by changes in CD spectra. CD spectra were collected of the unmodiﬁed
E. coli H69 in absence of aminoglycoside (black line) and in the
presence of increasing concentrations of paromomycin (0.75–
9.00mM). In this example, the ellipticity increased with increasing con-
centration of paromomycin at low concentrations (0.75, 1.50 and
2.25mM; arrow up). At higher concentrations of paromoycin (3.00
4.50, 5.25, 6.00, 6.75, 7.50, 8.25 and 9.00mM; arrow down), the
ellipticity of the RNA decreased.
Nucleic Acids Research,2010, Vol.38, No. 9 3099were reasonable reﬂections of the change in heat capacity
of the system with the binding of ligand, titrations of the
unmodiﬁed E. coli H69 and the human H69 with
neomycin B were monitored by ITC (Figure 5). The
binding curves derived from the titrations were found
again to be best analyzed as a non-linear, two-site
binding. For the unmodiﬁed E. coli H69, the aﬃnity for
neomycin B at the primary binding site was identical to
that from the thermal denaturations, Kd=0.3±0.5mM.
However, the second site aﬃnity for neomycin B was con-
siderably lower than that derived from the thermal
denaturations (Kd=17.9 versus 4.3mM, respectively). In
comparison, neomycin B was bound by the human H69
domain with a ﬁrst site Kd of 55.1mM, as compared to the
1.5mM determined by the UV-monitored thermal
denaturations. The binding curve derived from the ITC
appears to reﬂect the additional, second site binding,
along with the primary site, and an analysis with a two
site ﬁtting was not achievable. The free energy of binding
of neomycin B by ITC was G 
37= 6.0kcal/mol in
comparison to G 
37= 8.2kcal/mol derived from the
thermal denaturations (Table 2).
H69 interaction with neomycin B observed by NMR
The NMR of RNA’s base paired imino protons are highly
sensitive to changes in dynamics. Therefore, in order to
identify and observe the speciﬁc nucleosides of H69 that
interact with neomycin B, we titrated the E. coli
unmodiﬁed H69 (0.3mM) with neomycin B (0.1–
0.3mM) and monitored these resonances. As a result,
upon complex formation, the imino protons of the
residues which are involved in the interaction with
neomycin B, should give rise to detectable shifts and con-
siderable line broadening of their corresponding reso-
nances compared to those of the free H69. This allowed
us the unambiguous identiﬁcation of the RNA bases
which may be involved in the interaction with neomycin
B. The advantage of this approach is that RNA imino
proton resonances are typically found at the low ﬁeld
end of the NMR spectrum (57), and thus any changes to
them can be selectively monitored without interference
from the neomycin B resonances.
Prior to the above-mentioned titration, the imino
protons of the free H69 were identiﬁed and assigned by
using a combination of
1H 1D and 2D NOESY NMR
experiments run at 2 C and in aqueous solvent (see
Materials and Methods section). The results of these
experiments yielded six imino proton resonances
observed between 11.00 and 14.00ppm (Figure 6A). The
identiﬁed peaks were sequentially and speciﬁcally assigned
by using the cross-peaks observed in the same spectral
region of the 2D NOESY spectrum (Figure 7). The two
imino protons engaged in the wobble base pair G1907–
U1923 were readily identiﬁed and assigned due to their
distinctive chemical shifts found at 11.62 and 12.06ppm
(Table 3). This preliminary result constituted the starting
point for the assignment of G1910, G1921 and G1922
Figure 5. ITC of neomycin B binding to the unmodiﬁed E. coli and
human H69 hairpins. The unmodiﬁed E. coli and human H69 hairpins
were titrated with neomycin and the change in heat capacity monitored
by ITC. (A) Titration of the unmodiﬁed E. coli H69 with neomycin B
as monitored by ITC. The ITC proﬁle for the titration of the
unmodiﬁed E. coli H69 with neomycin B was conducted at 37 C.
Each heat burst is the result of a 10mL injection of 250mM
neomycin. (B) Binding of neomycin by the unmodiﬁed E. coli (ﬁlled
square) and human H69 RNAs (ﬁlled circle). The corrected injection
heats (kcal/mol) are derived by integration of the corresponding heat
burst curves (A) and corrected for background. The data for the titra-
tion of the human H69 has been normalized to that of the E. coli H69
in order to plot them on the same graph.
Figure 6. Detection of the based paired imino protons of unmodiﬁed
E. coli H69 by NMR. The base-paired, imino proton region of the
one-dimensional
1H NMR spectra of H69 exhibited six low ﬁeld
shifted resonances between 11.00 and 14.00ppm: (A) H69-neomycin
B complex. The line broadening of all resonances and the dramatic
chemical shift change of G1906 and G1921 could be observed in
comparison to the free H69 (B). H69–neomycin B complex. The line
broadening of all resonances and the dramatic chemical shift change of
G1906 and G1921 could be observed in comparison to the free H69
(B).
3100 Nucleic Acids Research, 2010,Vol.38, No. 9imino protons (Figure 7; Table 3). The broad peak
observed at 12.83ppm on the 1D spectrum of the H69
(Figure 6A; Table 3) could not be identiﬁed on the
NOESY spectrum indicating a fast exchange between
the corresponding imino proton and the protons of
water. The fast exchange could be due to the fraying of
the terminal stem base pair G1906–C1924 and therefore,
this resonance was assigned to the G1906 imino proton.
The identiﬁcation and assignment of U1911 imino pro-
tons and the non-hydrogen bonded imino protons of the
loop residues were prevented by this property of fast
exchange (57).
Following the addition of 1.0 equivalent of neomycin B,
the resonance intensities of all imino protons broadened
(Figure 6B). However, a comparison of the chemical shift
of the base pair imino protons in the presence of 0 and 1.0
equivalent of neomycin B displayed some speciﬁc and sig-
niﬁcant diﬀerences (Table 3). The result showed that the
G1906 base pair imino proton resonance was signiﬁcantly
shifted to the high ﬁeld by 0.62ppm and G1921 to the low
ﬁeld by 0.14ppm. G1907 and G1922 resonances were
shifted to the high ﬁeld by 0.06ppm whereas the shift
for U1923 and G1910 resonance was by 0.01ppm. The
assignment of G1906 was conﬁrmed by using
1H1 D
NOE diﬀerence spectroscopy recorded before and after
the titration (Figure 8).
DISCUSSION
Correct ribosome assembly and function are dependent on
the W1911, W1915 and W1917 modiﬁcations in the loop of
the bacterial H69 (58). However, their presence did not
contribute appreciably to aminoglycoside binding. We
found that paromomycin bound the W-modiﬁed E. coli
H69 with a Kd similar to that of the unmodiﬁed RNA.
The crystal structures of aminoglycosides bound to the
E. coli ribosome show that the binding site is located
mostly on the 30-side of the H69 stem and adjacent to
the loop with the closest modiﬁcation, W1917, being 3–4
nucleosides distant (15). In addition, W-modiﬁed RNA
loops are known to have only subtle diﬀerences in their
structures and stabilities in comparison to the unmodiﬁed
RNA (30,31,33,46). Thus, the modiﬁcations of the H69,
occurring also in the native human H69, may not be
factors in the binding of aminoglycosides. At this time,
we have not compared the binding of aminoglycosides
to the unmodiﬁed human H69 to that of the modiﬁed.
Figure 8. Escherichia coli unmodiﬁed H69
1H 1D NOE diﬀerence
NMR experiments. (A) The G1906 imino proton resonance of the
free H69 is irradiated. G1906 and G1910 respective imino proton res-
onances were found to be in close proximity and as a consequence the
irradiation of G1906 imino proton resonance expanded to G1910 and
this, in addition to spin diﬀusion, resulted in the observation of very
weak NOE eﬀects between G1906 and all residues. (B) The G1906
imino proton resonance of the free H69 is irradiated in the presence
of neomycin. Strong NOE eﬀects are observed between G1906 and
G1907, U1923 and G1921. Knowing that U1923 is adjacent to
G1906, the NOE eﬀect detected between these residues could be par-
tially due to the spillage of G1906 resonance irradiation over the peak
of U1923. The observation of an intense NOE between G1906 and the
distant peak of G1907 imino proton allow us to conclude that
neomycin could have restricted the dynamics of H69 upon H69–
neomycin B complex formation. Arrow denotes the irradiated peak
and asterisks denote the resulting NOE eﬀects.
Figure 7.
1H 2D NOESY spectrum of the unmodiﬁed E. coli H69.
The 2D spectrum is expanded in order to focus on the imino protons
resonance region (F1=11.00–13.90ppm; F2=11.00–13.50). The
sequential NOE connectivities between imino protons in H69 are
shown and were used to unambiguously assign the base paired protons.
Table 3. NMR titration of E.coli unmodiﬁed H69 with neomycin
Residue Free H69  1
(ppm)
Complex H69–neomycin
B  2 (ppm)
 ,
(d2 d1)
G1906 12.83 12.21  0.62
G1907 11.62 11.56  0.06
G1910 12.69 12.68  0.01
G1921 12.29 12.43 0.14
G1922 13.37 13.31  0.06
U1923 12.06 12.07 0.01
Chemical shift (d, ppm) of the imino proton resonances after the
addition 1.0 eq. of neomycin. Data based on Figure 6.
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loop (nucleosides 3727, 3731, 3733), but also in the stem
(3737 and 3739; Figure 1A) (31) at the potential binding
site that is analogous to that of the E. coli H69. It might be
useful in the future to conduct aminoglycoside binding
experiments using the modiﬁed human H69 to determine
if the Ws inﬂuence binding to a greater degree than with
the E. coli counterpart.
Aminoglycoside antibiotics are known to vary consid-
erably in their binding to RNAs, exhibiting distinctly dif-
ferent aﬃnities that depend on the RNA, and on the
conditions (6–8,59). Aﬃnities have been found to vary
as much as two orders of magnitude when comparing dif-
ferent RNAs, and even the same RNA but diﬀerent exper-
imental conditions and methods (60–62). In addition, the
ﬁnding that the data best ﬁts a two-site binding analysis is
not uncommon for model systems (49,50,63,64), as we
have found for H69. From the Hill analysis, the binding
of aminoglycoside to the primary binding site may provide
a conformational change that promotes the secondary
binding. However, the second site binding is most likely
due to non-speciﬁc electrostatic interactions of the posi-
tively charged amines of the antibiotic with the RNA
backbone, especially in the absence of competing mono-
and divalent cations (50). Our studies were conducted in
the presence of  50mM Na
+ far exceeding the 1mM con-
centration of the heptadecamer H69 constructs. However,
the assay conditions did not include divalent ions (Mg
2+)
with which the aminoglycosides would compete for
binding to the RNA backbone, nor changes in pH that
appear to aﬀect the structure of the W-modiﬁed E. coli
H69 (65). In the X-ray crystallographic structure (15),
the unique aminoglycoside-binding site is in the major
groove of H69 at the base of its stem, which would
contact the P-site. We hypothesized that the binding of
aminoglycosides to the secondary binding site was not
observed in the case of the crystal structure as a result
of a speciﬁc conformation adopted by H69 during crystal-
lization that prevented the observation of a secondary
binding site. It is also possible that the interactions
between H69 and the P-site could also have an inhibi-
tory eﬀect of the formation of a secondary
aminoglycoside-binding site.
The unmodiﬁed E. coli H69 hairpin bound the four
aminoglycoside antibiotics with signiﬁcantly diﬀerent
aﬃnities (Table 1). Neomycin B and tobramycin were
bound by H69 with nanomolar dissociation constants,
whereas paromomycin was bound with micromolar Kds
(Table 1). Streptomycin was not bound at all. The
binding aﬃnities derived from the UV-monitored
thermal denaturations were for the most part conﬁrmed
by CD and ITC. Larger diﬀerences in binding constants
were evident with the weaker binding of aminoglycosides
to the human H69. The binding mechanism of
aminoglycosides is both electrostatic and H-bonding
(50,59,64,66,67). Thus, it is no surprise that the highest
aﬃnity was exhibited by neomycin B with six amines,
ﬁve of which would be charged at the pH of the assay
(49). Both tobramycin and paromomycin have ﬁve
amines, of which four would be protonated, and strepto-
mycin has one. RNA aﬃnity for the aminoglycosides
tends to heavily relate to the number of amines (14) and
is diminished with increasing ionic strength and higher pH
of the solution in which they are tested (49,65).
Signiﬁcantly, neomycin B and tobramycin have two
amines on each of rings I and II, whereas paromomycin
has but one amine on ring I (Figure 1D and E). In
contrast, streptomycin has but a methylamine on ring I,
and no amine on ring II (Figure 1F). Neither of the E. coli
nor the human H69 constructs bound streptomycin.
Streptomycin-binding aptamers have provided insights
into its molecular recognition of RNA in solution and in
crystal (68,69). The crystal structure of streptomycin
bound to an RNA aptamer revealed that the para- and
ortho-substituted guanidinium groups of ring III play
critical roles in its molecular recognition of the RNA
aptamers. Perhaps, they were unable to do so with the
H69 constructs.
These diﬀerences in binding altered the Tm of the RNA
and were probably enthalpic in origin. Not only were
there distinguishing diﬀerences among the four
aminoglycosides, but binding aﬃnities of the individual
antibiotics for the E. coli H69 diﬀered from that of the
human H69 suggesting that the sequence and conforma-
tion of the prokaryotic RNA were more suitable for
binding. Paromomycin (as well as other neomycin-class
aminoglycosides) protect bases A1408 and G1494 of the
bacterial h44 from chemical probes. A1408 is one-third of
an adenine platform, also comprised of A1492 and A1493,
which helps to stabilize the RNA. The crystal structure of
paromomycin bound to the eubacterial A-site conﬁrmed
the importance of both nucleotides to the aminoglycoside–
RNA interaction (11). Yet, the base re-orientation of
A1492 and A1493 associated with the binding of tRNA
to h44 is not restricted by the presence of paromomycin
(11,70). In comparison, the dynamic character of H69
appears restricted with the binding of aminoglycosides
(15). The crystal structures of aminoglycosides binding
to E. coli H69 demonstrate interactions that mainly
employ the G1921, U1923 and the cross strand G1906.
Thus, the A-platform found in the terminal loop of H69
does not appear to be involved directly in the binding of
aminoglycosides. H69 hairpin sequences with one or more
antibiotics could conﬁrm that the aminoglycoside binding
to the 30-side of the stem and do not require the
A-platform. Our NMR studies of the unmodiﬁed H69
hairpin sequence with neomycin B and under solution
conditions identical to those of the UV and CD investiga-
tions did conﬁrm that the aminoglycosides bind to the
30-side of the H69 stem and involve G1906 and G1921.
Aminoglycosides have been used successfully as antibi-
otics for a long time and are now used also as experimen-
tal therapies for cystic ﬁbrosis and Duchenne’s muscular
dystrophy to counter non-sense mutations (71). However,
their penetration of eucaryotic cells is compromised by the
amino group positive charges, and can be toxic to humans
at high concentrations. Therefore, one would expect they
would be ideal broad spectrum antibiotics at low concen-
trations. Yet, the membranes of gram-positive bacteria
prevent uptake, modiﬁcation enzymes in bacteria alter
eﬃcacy and an oxygen-dependent transport system is
required, thus negating their use against anaerobic
3102 Nucleic Acids Research, 2010,Vol.38, No. 9pathogens (67,71). In addition, the positive charge is a
hindrance to uptake by gram-negative bacteria.
Bioavailability is reduced by poor oral absorption, but
succeeds very well in topical applications. The
positively-charged amino groups are attracted to and
bind the negatively-charged phosphate backbone of
the RNA with an aﬃnity that competes with cations.
Still, there is a speciﬁcity for RNA structure as
demonstrated by the aminoglycoside binding to only two
sites on the bacterial ribosome, helix 44 at the decoding
site of the small subunit (11), and at the stem and loop of
helix 69 of the large subunit at the interface with the small
subunit (15). As we have shown, the diﬀerent
aminoglycosides exhibit distinct binding properties for
the stem and loop of helix 69 and bind the human coun-
terpart to a lesser degree. Perhaps through alteration of
the aminoglycoside structures (67), tobramycin and
neomycin uptake and eﬃcacy as antibiotics can be
increased while maintaining diﬀerential absorption to
humans without increasing toxicity.
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